Mehdi Maghsudi

CV
h-index17
3papers
11citations
Novelty40%
AI Score35

3 Papers

CVNov 25, 2024
Enhanced Lung Cancer Survival Prediction using Semi-Supervised Pseudo-Labeling and Learning from Diverse PET/CT Datasets

Mohammad R. Salmanpour, Arman Gorji, Amin Mousavi et al.

Objective: This study explores a semi-supervised learning (SSL), pseudo-labeled strategy using diverse datasets to enhance lung cancer (LCa) survival predictions, analyzing Handcrafted and Deep Radiomic Features (HRF/DRF) from PET/CT scans with Hybrid Machine Learning Systems (HMLS). Methods: We collected 199 LCa patients with both PET & CT images, obtained from The Cancer Imaging Archive (TCIA) and our local database, alongside 408 head&neck cancer (HNCa) PET/CT images from TCIA. We extracted 215 HRFs and 1024 DRFs by PySERA and a 3D-Autoencoder, respectively, within the ViSERA software, from segmented primary tumors. The supervised strategy (SL) employed a HMLSs: PCA connected with 4 classifiers on both HRF and DRFs. SSL strategy expanded the datasets by adding 408 pseudo-labeled HNCa cases (labeled by Random Forest algorithm) to 199 LCa cases, using the same HMLSs techniques. Furthermore, Principal Component Analysis (PCA) linked with 4 survival prediction algorithms were utilized in survival hazard ratio analysis. Results: SSL strategy outperformed SL method (p-value<0.05), achieving an average accuracy of 0.85 with DRFs from PET and PCA+ Multi-Layer Perceptron (MLP), compared to 0.65 for SL strategy using DRFs from CT and PCA+ K-Nearest Neighbor (KNN). Additionally, PCA linked with Component-wise Gradient Boosting Survival Analysis on both HRFs and DRFs, as extracted from CT, had an average c-index of 0.80 with a Log Rank p-value<<0.001, confirmed by external testing. Conclusions: Shifting from HRFs and SL to DRFs and SSL strategies, particularly in contexts with limited data points, enabling CT or PET alone to significantly achieve high predictive performance.

MED-PHJul 10, 2025
Robust Semi-Supervised CT Radiomics for Lung Cancer Prognosis: Cost-Effective Learning with Limited Labels and SHAP Interpretation

Mohammad R. Salmanpour, Amir Hossein Pouria, Sonia Falahati et al.

Background: CT imaging is vital for lung cancer management, offering detailed visualization for AI-based prognosis. However, supervised learning SL models require large labeled datasets, limiting their real-world application in settings with scarce annotations. Methods: We analyzed CT scans from 977 patients across 12 datasets extracting 1218 radiomics features using Laplacian of Gaussian and wavelet filters via PyRadiomics Dimensionality reduction was applied with 56 feature selection and extraction algorithms and 27 classifiers were benchmarked A semi supervised learning SSL framework with pseudo labeling utilized 478 unlabeled and 499 labeled cases Model sensitivity was tested in three scenarios varying labeled data in SL increasing unlabeled data in SSL and scaling both from 10 percent to 100 percent SHAP analysis was used to interpret predictions Cross validation and external testing in two cohorts were performed. Results: SSL outperformed SL, improving overall survival prediction by up to 17 percent. The top SSL model, Random Forest plus XGBoost classifier, achieved 0.90 accuracy in cross-validation and 0.88 externally. SHAP analysis revealed enhanced feature discriminability in both SSL and SL, especially for Class 1 survival greater than 4 years. SSL showed strong performance with only 10 percent labeled data, with more stable results compared to SL and lower variance across external testing, highlighting SSL's robustness and cost effectiveness. Conclusion: We introduced a cost-effective, stable, and interpretable SSL framework for CT-based survival prediction in lung cancer, improving performance, generalizability, and clinical readiness by integrating SHAP explainability and leveraging unlabeled data.

CVOct 19, 2025
Click, Predict, Trust: Clinician-in-the-Loop AI Segmentation for Lung Cancer CT-Based Prognosis within the Knowledge-to-Action Framework

Mohammad R. Salmanpour, Sonya Falahati, Amir Hossein Pouria et al.

Lung cancer remains the leading cause of cancer mortality, with CT imaging central to screening, prognosis, and treatment. Manual segmentation is variable and time-intensive, while deep learning (DL) offers automation but faces barriers to clinical adoption. Guided by the Knowledge-to-Action framework, this study develops a clinician-in-the-loop DL pipeline to enhance reproducibility, prognostic accuracy, and clinical trust. Multi-center CT data from 999 patients across 12 public datasets were analyzed using five DL models (3D Attention U-Net, ResUNet, VNet, ReconNet, SAM-Med3D), benchmarked against expert contours on whole and click-point cropped images. Segmentation reproducibility was assessed using 497 PySERA-extracted radiomic features via Spearman correlation, ICC, Wilcoxon tests, and MANOVA, while prognostic modeling compared supervised (SL) and semi-supervised learning (SSL) across 38 dimensionality reduction strategies and 24 classifiers. Six physicians qualitatively evaluated masks across seven domains, including clinical meaningfulness, boundary quality, prognostic value, trust, and workflow integration. VNet achieved the best performance (Dice = 0.83, IoU = 0.71), radiomic stability (mean correlation = 0.76, ICC = 0.65), and predictive accuracy under SSL (accuracy = 0.88, F1 = 0.83). SSL consistently outperformed SL across models. Radiologists favored VNet for peritumoral representation and smoother boundaries, preferring AI-generated initial masks for refinement rather than replacement. These results demonstrate that integrating VNet with SSL yields accurate, reproducible, and clinically trusted CT-based lung cancer prognosis, highlighting a feasible path toward physician-centered AI translation.